EUVIMEDEUVIMED entdecken
Crossref

Macrophage Membrane-Cloaked ROS-Responsive Albumin Nanoplatforms for Targeted Delivery of Curcumin to Alleviate Acute Liver Injury

Dandan Hu, Zhenqiu Huang, Wenlong Li, Lianhai Shan, Ming-Yu Wu, Shun Feng iD, Yu Wan iD

Molecular Pharmaceutics · 03.02.2025 · 22 (2) · 771-786

DOI: 10.1021/acs.molpharmaceut.4c00808 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 09.01.2025. Verfasst von Dandan Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University,…. Hauptthemen laut MEDLINE: Curcumin, Reactive Oxygen Species, Macrophages, Nanoparticles. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China, Technical Innovation Research and Development Project of Chengdu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Developing low-toxicity, high-efficacy, and fast-acting strategies to manage acute liver injury (ALI) is critical due to its rapid progression and potential for severe outcomes. Curcumin (CUR) has shown promise in ALI therapy due to its ability to modulate the inflammatory microenvironment by scavenging reactive oxygen species (ROS). Nevertheless, CUR is highly hydrophobic limiting its bioavailability and effective in vivo transport, which hinders its further application. In this study, we developed an inflammatory microenvironment-targeted drug delivery system by covalently coupling human serum albumin (HSA) with ROS-sensitive thioketal linkers and loading it with CUR to form nanoparticles (HSA-TK/CUR). These nanoparticles were then coated with a macrophage membrane (CM@HSA-TK/CUR), resulting in negatively charged spherical particles (≈ -23.26 mV) with an average particle size of around 165 nm. ROS responsiveness was confirmed through drug release assays and enhanced ROS depletion was further demonstrated by Diacetyldichlorofluorescein (DCFH-DA) ROS detection experiments. CM@HSA-TK/CUR treatment resulted in a 94.7% reduction in ROS levels in inflammatory cells. In addition, cellular uptake and in vivo distribution experiments demonstrated that camouflaging HSA-TK/CUR with macrophage membranes significantly enhanced its targeting of the inflammatory microenvironment. The findings revealed that CM@HSA-TK/CUR rapidly accumulated in the injured liver within 6 h, inhibited the production of pro-inflammatory factors (IL-1β, IL-6, and TNF-α), shifted macrophage polarization from M1 to M2 in vivo, and protected hepatocytes from oxidative stress-associated cell death, significantly attenuating the inflammatory response in ALI mice. In conclusion, CM@HSA-TK/CUR has excellent potential in treating mice with ALI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminReactive Oxygen SpeciesMacrophagesNanoparticlesSerum Albumin, HumanAnimalsMiceHumansDrug Delivery SystemsRAW 264.7 CellsMaleDrug LiberationChemical and Drug Induced Liver Injury

Stichwörter der Autor:innen

acute liver injurybiomimetic nanoparticlesdrug deliveryendogenous ROS-responsive nanocarrierinflammatory microenvironment targeting

Substanzen

CurcuminReactive Oxygen SpeciesSerum Albumin, Human

Autor:innen und Institutionen

  • Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China.

ORCID-Profile: Shun Feng, Yu Wan

Förderung

  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Technical Innovation Research and Development Project of Chengdu

Zitieren

APA

Hu, D., Huang, Z., Li, W., Shan, L., Wu, M. Y., Feng, S., & Wan, Y. (2025). Macrophage Membrane-Cloaked ROS-Responsive Albumin Nanoplatforms for Targeted Delivery of Curcumin to Alleviate Acute Liver Injury. Molecular Pharmaceutics, 22(2), 771-786. https://doi.org/10.1021/acs.molpharmaceut.4c00808

Vancouver

Hu D, Huang Z, Li W, Shan L, Wu MY, Feng S, et al. Macrophage Membrane-Cloaked ROS-Responsive Albumin Nanoplatforms for Targeted Delivery of Curcumin to Alleviate Acute Liver Injury. Molecular Pharmaceutics. 2025;22(2):771-786. doi:10.1021/acs.molpharmaceut.4c00808

BibTeX
@article{Hu2025,
  author = {Hu, Dandan and Huang, Zhenqiu and Li, Wenlong and Shan, Lianhai and Wu, Ming-Yu and Feng, Shun and Wan, Yu},
  title = {Macrophage Membrane-Cloaked ROS-Responsive Albumin Nanoplatforms for Targeted Delivery of Curcumin to Alleviate Acute Liver Injury},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  volume = {22},
  number = {2},
  pages = {771--786},
  doi = {10.1021/acs.molpharmaceut.4c00808}
}
Kostenlos starten →